Brokerages Set Repligen Co. (NASDAQ:RGEN) PT at $173.25
Repligen Co. (NASDAQ:RGEN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the fourteen research firms that are covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price target among brokers […]
Repligen Co. (NASDAQ:RGEN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the fourteen research firms that are covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price target among brokers […]
